StreetAlpha
Spyre Therapeutics, Inc. · SEC Form 4

SYRE Insider Trading

From SEC Form 433 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Spyre Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $442M sold.

← SYRE stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$442M30 sales · 7 insiders
Net−$442Mbought minus sold
Planned sales9%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $435KDec2026-01: sold $460KJan2026-02: sold $492KFeb2026-03: sold $734KMar2026-04: sold $1.5MApr2026-05: sold $13.5MMay2026-06: sold $405MJun2026-07: sold $2.7MJul2026-08: sold $4.6MAug2026-09: sold $6.1MSep2026-10: sold $6.3MOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when SYRE insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an SYRE officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every SYRE insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 1, 2026Scott L BurrowsCFOSale plan25,000$90.47$2.3M79,762Oct 2Form 4
Oct 1, 2026Cameron TurtleCEOSale plan15,000$92.01$1.4M537,540Oct 2Form 4
Oct 1, 2026Heidy King-JonesSee RemarksSale plan28,933$91.03$2.6M2,845Oct 2Form 4
Sep 2, 2026Scott L BurrowsCFOSale plan25,732$88.75$2.3M79,762Sep 3Form 4
Sep 2, 2026Heidy King-JonesSee RemarksSale plan28,399$87.35$2.5M2,845Sep 3Form 4
Sep 1, 2026Cameron TurtleCEOSale plan15,000$87.29$1.3M552,540Sep 3Form 4
Aug 7, 2026Jeffrey W. AlbersDirectorSale plan23,000$104.53$2.4M9,360Aug 10Form 4
Aug 3, 2026Cameron TurtleCEOSale plan15,000$95.51$1.4M567,540Aug 5Form 4
Aug 3, 2026Scott L BurrowsCFOSale plan7,500$95.57$717K97,994Aug 5Form 4
Jul 1, 2026Cameron TurtleCEOSale plan15,000$87.69$1.3M582,540Jul 2Form 4
Jul 1, 2026Sheldon SloanChief Medical OfficerSale plan8,334$87.70$731K0Jul 2Form 4
Jul 1, 2026Scott L BurrowsCFOSale plan7,500$87.74$658K97,994Jul 2Form 4
Jun 25, 2026Scott L BurrowsCFOSale15,000$87.13$1.3M97,994Jun 26Form 4
Jun 23, 2026Fairmount Funds Management LLCDirectorSale4,684,781$85.31$400M0Jun 23Form 4
Jun 22, 2026Michael Thomas HendersonDirectorSale plan20,000$100.00$2M68,606Jun 23Form 4
🔒 18 more trades. Create a free account or sign in to see them all.

SYRE insider trading FAQ

Are SYRE insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of SYRE on the open market in 0 trades, and 7 sold $442M in 30 trades, 9% of that under pre-arranged trading plans.

When did an SYRE insider last buy shares?

There has been no open market insider purchase of SYRE in the last two years.

When did an SYRE insider last sell shares?

Scott L Burrows (CFO) sold 25,000 shares for $2.3M on Oct 1, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice